Breast (Mar 2023)

SA 5.1 Post-neoadjuvant options in triple negative disease: PARPi, capecitabine, checkpoint inhibitors

  • J. Cortes

Journal volume & issue
Vol. 68
p. S5

Abstract

Read online

No abstracts available.